Position in RCKT
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,031,983
-$157,309 QoQ
Shares Held
288,264
-14.9% QoQ
Ownership
0.264%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 66%
Shared 14%
None 20%
Common Shares in RCKT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. RCKT ranks #145 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in RCKT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,031,983 | 288,264 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,189,292 | 338,830 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,811,981 | 555,823 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,371,876 | 559,950 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,851,843 | 577,488 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $9,565,025 | 760,941 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $16,855,812 | 912,605 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $20,371,146 | 946,175 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $27,742,487 | 1,029,788 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $31,406,789 | 1,047,941 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $27,388,406 | 1,336,672 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $26,609,086 | 1,339,159 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $21,797,819 | 1,272,494 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $22,082,022 | 1,128,361 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $14,101,759 | 883,569 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,013,050 | 436,995 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,586,102 | 415,265 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $8,435,963 | 386,439 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $11,192,489 | 374,456 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $22,025,859 | 497,310 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $13,678,827 | 308,290 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $18,426,569 | 336,006 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $7,841,254 | 343,012 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $7,114,274 | 339,908 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,843,029 | 275,486 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||